MD
MDXHF.US MedX Health Corp
- Market cap
- USD 3.61M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MDXHF.US undervalued?
Graham numberThe Graham number of MedX Health Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MedX Health Corp fundamental analysis
No fundamental analysis for MedX Health Corp yet.
MedX Health Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation m…
Full company profileMedX Health Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MedX Health Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 817K | 1.09M | 1.09M | 860K | 530K | 563K | 511K | 456K | 490K | 473K | 593K |
| Gross Profit | 438K | 614K | 689K | 480K | 268K | 289K | 240K | 186K | 194K | -88.9K | 170K |
| Operating Income | -1.22M | -1.49M | -4.08M | -3.13M | -3.03M | -4.56M | -3.87M | -3.03M | -2.30M | -4.29M | -4.27M |
| EBITDA | -1.16M | -1.39M | -3.98M | -3.02M | -3.06M | -4.54M | -3.82M | -2.38M | -2.26M | -4.24M | -4.21M |
| Net Income | -1.34M | -1.60M | -4.19M | -3.28M | -3.20M | -5.32M | -5.13M | -4.58M | -3.65M | -6.29M | -5.66M |
| EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.01 | -0.02 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 798K | 671K | 652K | 436K | 734K | 731K | 681K | 690K | 884K | 702K | 486K |
| Total Liabilities | 2.62M | 2.17M | 2.20M | 3.30M | 2.80M | 4.36M | 7.76M | 7.83M | 9.41M | 10.4M | 11.2M |
| Shareholders' Equity | -1.83M | -1.50M | -1.54M | -2.87M | -2.07M | -3.63M | -7.08M | -7.14M | -8.52M | -9.73M | -10.7M |
| Cash & Short-term Investments | 208K | 96.3K | 38.9K | 11.9K | 37.9K | 107K | 142K | 138K | 158K | 18.7K | 19.6K |
| Total Debt | 775K | 723K | 534K | 778K | 949K | 2.58M | 5.00M | 5.84M | 7.01M | 7.97M | 8.70M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.33M | -1.47M | -2.61M | -1.32M | -2.91M | -4.52M | -2.80M | -3.42M | -2.51M | -3.73M | -3.86M |
| Capital Expenditure | 3.64K | 1.17K | 10.9K | 4.44K | 5.50K | 16.5K | 0.00 | 0.00 | 0.00 | 2.10K | 0.00 |
| Free Cash Flow | -1.34M | -1.47M | -2.62M | -1.33M | -2.91M | -4.53M | -2.80M | -3.42M | -2.51M | -3.73M | -3.86M |
| Ratios | |||||||||||
| ROA | -167.3% | -239.1% | -642.0% | -751.6% | -435.7% | -728.2% | -753.8% | -664.2% | -413.2% | -895.6% | -1,164.5% |
| Net Profit Margin | -163.4% | -146.8% | -385.0% | -380.9% | -603.6% | -945.4% | -1,005.4% | -1,004.3% | -746.0% | -1,329.2% | -953.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MedX Health Corp dividends
MedX Health Corp has not paid dividends in the last 9 fiscal years.
Who owns MedX Health Corp
- Insiders 34.59%
- Institutions 0.00%
- Public & others 65.41%
- Shares outstanding 328M
- Free float 214M
MedX Health Corp company profile
- Company name
- MedX Health Corp
- Ticker
- MDXHF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- 1495 Bonhill Road, Mississauga, ON, Canada, L5T 1M2
- Phone
- 905 670 4428
- Website
- medxhealth.com
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It also provides DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.
MedX Health Corp management
7- Mr. John GevisserChief Executive Officer
- Mr. Stephen LockyerPresident & Director
- Mr. Christopher H. FreemanCorporate Secretary & Acting CFO
- Ms. Meghan GearyChief Operating Officer
- Mr. Michael DruhanPresident of Dermatological Services & Products
- Mr. Heinrich De LangeChief Technology Officer
- Mr. Scott NaughtonManaging Director of US Operations